Johnson & Johnson, Abbott Labs, and Philip Morris' Earnings: A Preview
- July 20th, 2023
- 438 views
On Thursday, July 20, three prominent companies are set to unveil their financial results:
Johnson & Johnson (NYSE: JNJ), a leading pharmaceutical and consumer goods company, will announce its second-quarter 2023 results before the market opens.
Analysts are projecting an EPS of $2.62 on revenue of $24.63 billion.
On Wednesday, $JNJ closed at $158.74, down $0.32 (-0.20%).
Abbott Laboratories (NYSE: ABT), a diversified healthcare company, will report its second-quarter 2023 financial results prior to the market opening.
The consensus estimate expects an EPS of $1.05 on revenue of $9.7 billion.
$ABT closed at $107.28 on Wednesday, reflecting a gain of $0.33 (+0.31%).
Philip Morris International Inc. (NYSE: PM), a leading tobacco company, will release its 2023 second-quarter and first-half results before the market opens.
Analysts forecast an EPS of $1.47 on revenue of $8.65 billion.
On Wednesday, $PM closed at $98.77, up $0.42 (+0.43%).
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)
Post Your Comments
Want To Find Some News?
Recent Posts
-
NJCP National Football Conference Names David Dalton Head Coach of Salt Lake Yeti
February 06th, 2026FDA Takes New Approach to "No Artificial Colors" Claims
February 06th, 2026NJCP National Football Conference Announces Micah Deckart as Head Coach of the Idaho Outlaws
February 05th, 2026
Member Login